Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen - Archive ouverte HAL Access content directly
Journal Articles Pharmacogenomics Year : 2013

Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen

(1) , (2) , (3, 1) , (2) , (2) , (4) , (5, 1) , (1, 4) , (6, 2)
1
2
3
4
5
6
Not file

Dates and versions

hal-01708020 , version 1 (13-02-2018)

Identifiers

Cite

Cindy Serdjebi, Jean-François Seitz, Joseph Ciccolini, Muriel Duluc, Emmanuelle Norguet, et al.. Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen. Pharmacogenomics, 2013, 14 (9), pp.1047 - 1051. ⟨10.2217/pgs.13.93⟩. ⟨hal-01708020⟩
29 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More